Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Sigma Healthcare Ltd ( (AU:SIG) ) just unveiled an update.
Sigma Healthcare Ltd is set to release its FY25 Full Year results on August 27, 2025, following its acquisition of the Chemist Warehouse Group. This acquisition is treated as a reverse acquisition for accounting purposes, impacting the presentation of financial statements. The results will include a full twelve-month contribution from CWG, and Sigma will provide normalised and pro forma financial results to adjust for merger-related costs. This strategic move is expected to enhance Sigma’s market positioning and provide stakeholders with a clearer view of its financial health post-acquisition.
The most recent analyst rating on (AU:SIG) stock is a Buy with a A$3.45 price target. To see the full list of analyst forecasts on Sigma Healthcare Ltd stock, see the AU:SIG Stock Forecast page.
More about Sigma Healthcare Ltd
Sigma Healthcare Ltd operates in the healthcare industry, primarily focusing on pharmaceutical distribution and retail services. The company is involved in the acquisition and integration of the Chemist Warehouse Group, which positions it as a significant player in the Australian pharmaceutical market.
YTD Price Performance: 9.16%
Average Trading Volume: 37,070,080
Technical Sentiment Signal: Buy
Current Market Cap: A$32.84B
For a thorough assessment of SIG stock, go to TipRanks’ Stock Analysis page.